Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2016 | Pages:
735 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Asthma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Pipeline Review, H2 2016, provides an overview of the Asthma (Respiratory) pipeline landscape. Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow air to come in and out of the lungs. Symptoms include shortness of breath, chest tightness or pain, chronic coughing and trouble sleeping due to coughing or wheezing. The predisposing factors include family history, overweight, smoking, exposure to exhaust fumes or other types of pollution and exposure to occupational triggers, such as chemicals used in farming, hairdressing and manufacturing. Treatment includes inhaled corticosteroids, leukotriene modifiers, antihistamines and decongestants. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Asthma - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Asthma (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 6, 16, 44, 36, 124, 25 and 2 respectively for Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 24 and 8 molecules, respectively for Asthma. Asthma (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Asthma (Respiratory). - The pipeline guide reviews pipeline therapeutics for Asthma (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Asthma (Respiratory) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Asthma (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Asthma (Respiratory) Reasons To Buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Asthma (Respiratory). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Asthma (Respiratory) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2 Introduction 9 Asthma Overview 10 Therapeutics Development 11 Asthma - Therapeutics under Development by Companies 13 Asthma - Therapeutics under Investigation by Universities/Institutes 25 Asthma - Pipeline Products Glance 27 Asthma - Products under Development by Companies 31 Asthma - Products under Investigation by Universities/Institutes 48 Asthma - Companies Involved in Therapeutics Development 50 Asthma - Therapeutics Assessment 178 Drug Profiles 215 Asthma - Dormant Projects 645 Asthma - Discontinued Products 682 Asthma - Product Development Milestones 691 Appendix 704
List of Tables
Number of Products under Development for Asthma, H2 2016 41 Number of Products under Development for Asthma - Comparative Analysis, H2 2016 42 Number of Products under Development by Companies, H2 2016 44 Number of Products under Development by Companies, H2 2016 (Contd..1) 45 Number of Products under Development by Companies, H2 2016 (Contd..2) 46 Number of Products under Development by Companies, H2 2016 (Contd..3) 47 Number of Products under Development by Companies, H2 2016 (Contd..4) 48 Number of Products under Development by Companies, H2 2016 (Contd..5) 49 Number of Products under Development by Companies, H2 2016 (Contd..6) 50 Number of Products under Development by Companies, H2 2016 (Contd..7) 51 Number of Products under Development by Companies, H2 2016 (Contd..8) 52 Number of Products under Development by Companies, H2 2016 (Contd..9) 53 Number of Products under Development by Companies, H2 2016 (Contd..10) 54 Number of Products under Investigation by Universities/Institutes, H2 2016 55 Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 56 Comparative Analysis by Late Stage Development, H2 2016 57 Comparative Analysis by Clinical Stage Development, H2 2016 58 Comparative Analysis by Early Stage Development, H2 2016 59 Comparative Analysis by Unknown Stage Development, H2 2016 60 Products under Development by Companies, H2 2016 61 Products under Development by Companies, H2 2016 (Contd..1) 62 Products under Development by Companies, H2 2016 (Contd..2) 63 Products under Development by Companies, H2 2016 (Contd..3) 64 Products under Development by Companies, H2 2016 (Contd..4) 65 Products under Development by Companies, H2 2016 (Contd..5) 66 Products under Development by Companies, H2 2016 (Contd..6) 67 Products under Development by Companies, H2 2016 (Contd..7) 68 Products under Development by Companies, H2 2016 (Contd..8) 69 Products under Development by Companies, H2 2016 (Contd..9) 70 Products under Development by Companies, H2 2016 (Contd..10) 71 Products under Development by Companies, H2 2016 (Contd..11) 72 Products under Development by Companies, H2 2016 (Contd..12) 73 Products under Development by Companies, H2 2016 (Contd..13) 74 Products under Development by Companies, H2 2016 (Contd..14) 75 Products under Development by Companies, H2 2016 (Contd..15) 76 Products under Development by Companies, H2 2016 (Contd..16) 77 Products under Investigation by Universities/Institutes, H2 2016 78 Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 79 Asthma - Pipeline by 4D Pharma Plc, H2 2016 80 Asthma - Pipeline by AB Science SA, H2 2016 81 Asthma - Pipeline by AbbVie Inc, H2 2016 82 Asthma - Pipeline by Abeome Corporation, H2 2016 83 Asthma - Pipeline by Accolade Pharmaceuticals, LLC, H2 2016 84 Asthma - Pipeline by Acorda Therapeutics, Inc., H2 2016 85 Asthma - Pipeline by Adamis Pharmaceuticals Corporation, H2 2016 86 Asthma - Pipeline by Advinus Therapeutics Ltd, H2 2016 87 Asthma - Pipeline by Afferent Pharmaceuticals, Inc., H2 2016 88 Asthma - Pipeline by ALK-Abello A/S, H2 2016 89 Asthma - Pipeline by Allergopharma GmbH & Co. KG, H2 2016 90 Asthma - Pipeline by Almirall, S.A., H2 2016 91 Asthma - Pipeline by Amakem NV, H2 2016 92 Asthma - Pipeline by Amgen Inc., H2 2016 93 Asthma - Pipeline by AnaptysBio, Inc., H2 2016 94 Asthma - Pipeline by AnGes MG, Inc., H2 2016 95 Asthma - Pipeline by Antisense Therapeutics Limited, H2 2016 96 Asthma - Pipeline by ARA Healthcare Pvt. Ltd., H2 2016 97 Asthma - Pipeline by Array BioPharma Inc., H2 2016 98 Asthma - Pipeline by ASIT biotech s.a., H2 2016 99 Asthma - Pipeline by Astellas Pharma Inc., H2 2016 100 Asthma - Pipeline by AstraZeneca Plc, H2 2016 101 Asthma - Pipeline by Asubio Pharma Co., Ltd., H2 2016 102 Asthma - Pipeline by Aurigene Discovery Technologies Limited, H2 2016 103 Asthma - Pipeline by Axikin Pharmaceuticals, Inc., H2 2016 104 Asthma - Pipeline by Bioncotech Therapeutics SL, H2 2016 105 Asthma - Pipeline by Biotec Pharmacon ASA, H2 2016 106 Asthma - Pipeline by Boehringer Ingelheim GmbH, H2 2016 107 Asthma - Pipeline by CalciMedica, Inc., H2 2016 108 Asthma - Pipeline by Cellceutix Corporation, H2 2016 109 Asthma - Pipeline by Cellular Biomedicine Group, Inc., H2 2016 110 Asthma - Pipeline by Celon Pharma Sp. z o.o., H2 2016 111 Asthma - Pipeline by Chiesi Farmaceutici SpA, H2 2016 112 Asthma - Pipeline by Circassia Pharmaceuticals Plc, H2 2016 113 Asthma - Pipeline by Cognosci, Inc., H2 2016 114 Asthma - Pipeline by CSL Limited, H2 2016 115 Asthma - Pipeline by Cumberland Pharmaceuticals, Inc., H2 2016 116 Asthma - Pipeline by Cynata Therapeutics Limited, H2 2016 117 Asthma - Pipeline by Daiichi Sankyo Company, Limited, H2 2016 118 Asthma - Pipeline by F. Hoffmann-La Roche Ltd., H2 2016 119 Asthma - Pipeline by Foresee Pharmaceuticals, LLC, H2 2016 120 Asthma - Pipeline by Fountain Biopharma Inc., H2 2016 121 Asthma - Pipeline by Genentech, Inc., H2 2016 122 Asthma - Pipeline by GlaxoSmithKline Plc, H2 2016 123 Asthma - Pipeline by Griffin Discoveries BV, H2 2016 124 Asthma - Pipeline by Han Wha Pharma Co., Ltd., H2 2016 125 Asthma - Pipeline by HitGen LTD, H2 2016 126 Asthma - Pipeline by Hydra Biosciences, Inc., H2 2016 127 Asthma - Pipeline by iCeutica, Inc., H2 2016 128 Asthma - Pipeline by iCo Therapeutics Inc., H2 2016 129 Asthma - Pipeline by Immupharma Plc, H2 2016 130 Asthma - Pipeline by Infinity Pharmaceuticals, Inc., H2 2016 131 Asthma - Pipeline by INOXIA Lifesciences GmbH, H2 2016 132 Asthma - Pipeline by Intech Biopharm Ltd, H2 2016 133 Asthma - Pipeline by Invion Limited, H2 2016 134 Asthma - Pipeline by Jiangsu Hansoh Pharmaceutical Co., Ltd., H2 2016 135 Asthma - Pipeline by Johnson & Johnson, H2 2016 136 Asthma - Pipeline by Kissei Pharmaceutical Co., Ltd., H2 2016 137 Asthma - Pipeline by Kolltan Pharmaceuticals, Inc., H2 2016 138 Asthma - Pipeline by KPI Therapeutics, Inc., H2 2016 139 Asthma - Pipeline by Kyowa Hakko Kirin Co., Ltd., H2 2016 140 Asthma - Pipeline by Lead Discovery Center GmbH, H2 2016 141 Asthma - Pipeline by LegoChem Biosciences, Inc, H2 2016 142 Asthma - Pipeline by Ligand Pharmaceuticals, Inc., H2 2016 143 Asthma - Pipeline by Lpath, Inc., H2 2016 144 Asthma - Pipeline by Mabtech Limited, H2 2016 145 Asthma - Pipeline by Marinomed Biotechnologie GmbH, H2 2016 146 Asthma - Pipeline by MedImmune, LLC, H2 2016 147 Asthma - Pipeline by Merck & Co., Inc., H2 2016 148 Asthma - Pipeline by Mitsubishi Tanabe Pharma Corporation, H2 2016 149 Asthma - Pipeline by Mycenax Biotech Inc., H2 2016 150 Asthma - Pipeline by NAL Pharmaceuticals Ltd., H2 2016 151 Asthma - Pipeline by NeoPharm Co., Ltd., H2 2016 152 Asthma - Pipeline by Novartis AG, H2 2016 153 Asthma - Pipeline by Omeros Corporation, H2 2016 154 Asthma - Pipeline by Ono Pharmaceutical Co., Ltd., H2 2016 155 Asthma - Pipeline by OPKO Health, Inc., H2 2016 156 Asthma - Pipeline by Orbis Biosciences Inc, H2 2016 157 Asthma - Pipeline by Orion Oyj, H2 2016 158 Asthma - Pipeline by Oxagen Limited, H2 2016 159 Asthma - Pipeline by Palatin Technologies, Inc., H2 2016 160 Asthma - Pipeline by Panacea Biotec Limited, H2 2016 161 Asthma - Pipeline by Panmira Pharmaceuticals, LLC., H2 2016 162 Asthma - Pipeline by Paradigm Biopharmaceuticals Limited, H2 2016 163 Asthma - Pipeline by Peptinnovate Ltd, H2 2016 164 Asthma - Pipeline by Pfizer Inc., H2 2016 165 Asthma - Pipeline by PharmaLundensis AB, H2 2016 166 Asthma - Pipeline by Pharmaxis Limited, H2 2016 167 Asthma - Pipeline by Pieris Pharmaceuticals Inc, H2 2016 168 Asthma - Pipeline by Pila Pharma AB, H2 2016 169 Asthma - Pipeline by Polyphor Ltd., H2 2016 170 Asthma - Pipeline by Promedior, Inc., H2 2016 171 Asthma - Pipeline by Prommune, Inc., H2 2016 172 Asthma - Pipeline by Protectimmun GmbH, H2 2016 173 Asthma - Pipeline by Prous Institute for Biomedical Research S.A., H2 2016 174 Asthma - Pipeline by Pulmagen Therapeutics LLP, H2 2016 175 Asthma - Pipeline by Pulmokine, Inc., H2 2016 176 Asthma - Pipeline by Re-Pharm Limited, H2 2016 177 Asthma - Pipeline by Regeneron Pharmaceuticals Inc, H2 2016 178 Asthma - Pipeline by Respiratorius AB, H2 2016 179 Asthma - Pipeline by ReveraGen BioPharma, Inc., H2 2016 180 Asthma - Pipeline by Rhizen Pharmaceuticals S.A., H2 2016 181 Asthma - Pipeline by Saje Pharma, LLC, H2 2016 182 Asthma - Pipeline by Shire Plc, H2 2016 183 Asthma - Pipeline by Spring Bank Pharmaceuticals, Inc., H2 2016 184 Asthma - Pipeline by Stallergenes Greer plc, H2 2016 185 Asthma - Pipeline by sterna biologicals Gmbh & Co KG, H2 2016 186 Asthma - Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H2 2016 187 Asthma - Pipeline by Sun Pharma Advanced Research Company Ltd., H2 2016 188 Asthma - Pipeline by Sunovion Pharmaceuticals Inc., H2 2016 189 Asthma - Pipeline by Swecure AB, H2 2016 190 Asthma - Pipeline by Synermore Biologics Co Ltd, H2 2016 191 Asthma - Pipeline by Synovo GmbH, H2 2016 192 Asthma - Pipeline by Syntrix Biosystems, Inc., H2 2016 193 Asthma - Pipeline by TaiwanJ Pharmaceuticals Co., Ltd., H2 2016 194 Asthma - Pipeline by Takeda Pharmaceutical Company Limited, H2 2016 195 Asthma - Pipeline by Teva Pharmaceutical Industries Ltd., H2 2016 196 Asthma - Pipeline by The International Biotechnology Center (IBC) Generium, H2 2016 197 Asthma - Pipeline by Therabron Therapeutics, Inc., H2 2016 198 Asthma - Pipeline by Theravance Biopharma, Inc., H2 2016 199 Asthma - Pipeline by Tolerys SA, H2 2016 200 Asthma - Pipeline by United BioPharma, Inc., H2 2016 201 Asthma - Pipeline by Vectura Group Plc, H2 2016 202 Asthma - Pipeline by Verona Pharma Plc, H2 2016 203 Asthma - Pipeline by WhanIn Pharmaceutical Co., Ltd., H2 2016 204 Asthma - Pipeline by Xencor, Inc., H2 2016 205 Asthma - Pipeline by Yungjin Pharm. Co., Ltd., H2 2016 206 Asthma - Pipeline by Zambon Company S.p.A., H2 2016 207 Assessment by Monotherapy Products, H2 2016 208 Assessment by Combination Products, H2 2016 209 Number of Products by Stage and Target, H2 2016 211 Number of Products by Stage and Mechanism of Action, H2 2016 223 Number of Products by Stage and Route of Administration, H2 2016 242 Number of Products by Stage and Molecule Type, H2 2016 244 Asthma - Dormant Projects, H2 2016 675 Asthma - Dormant Projects (Contd..1), H2 2016 676 Asthma - Dormant Projects (Contd..2), H2 2016 677 Asthma - Dormant Projects (Contd..3), H2 2016 678 Asthma - Dormant Projects (Contd..4), H2 2016 679 Asthma - Dormant Projects (Contd..5), H2 2016 680 Asthma - Dormant Projects (Contd..6), H2 2016 681 Asthma - Dormant Projects (Contd..7), H2 2016 682 Asthma - Dormant Projects (Contd..8), H2 2016 683 Asthma - Dormant Projects (Contd..9), H2 2016 684 Asthma - Dormant Projects (Contd..10), H2 2016 685 Asthma - Dormant Projects (Contd..11), H2 2016 686 Asthma - Dormant Projects (Contd..12), H2 2016 687 Asthma - Dormant Projects (Contd..13), H2 2016 688 Asthma - Dormant Projects (Contd..14), H2 2016 689 Asthma - Dormant Projects (Contd..15), H2 2016 690 Asthma - Dormant Projects (Contd..16), H2 2016 691 Asthma - Dormant Projects (Contd..17), H2 2016 692 Asthma - Dormant Projects (Contd..18), H2 2016 693 Asthma - Dormant Projects (Contd..19), H2 2016 694 Asthma - Dormant Projects (Contd..20), H2 2016 695 Asthma - Dormant Projects (Contd..21), H2 2016 696 Asthma - Dormant Projects (Contd..22), H2 2016 697 Asthma - Dormant Projects (Contd..23), H2 2016 698 Asthma - Dormant Projects (Contd..24), H2 2016 699 Asthma - Dormant Projects (Contd..25), H2 2016 700 Asthma - Dormant Projects (Contd..26), H2 2016 701 Asthma - Dormant Projects (Contd..27), H2 2016 702 Asthma - Dormant Projects (Contd..28), H2 2016 703 Asthma - Dormant Projects (Contd..29), H2 2016 704 Asthma - Dormant Projects (Contd..30), H2 2016 705 Asthma - Dormant Projects (Contd..31), H2 2016 706 Asthma - Dormant Projects (Contd..32), H2 2016 707 Asthma - Dormant Projects (Contd..33), H2 2016 708 Asthma - Dormant Projects (Contd..34), H2 2016 709 Asthma - Dormant Projects (Contd..35), H2 2016 710 Asthma - Dormant Projects (Contd..36), H2 2016 711 Asthma - Discontinued Products, H2 2016 712 Asthma - Discontinued Products (Contd..1), H2 2016 713 Asthma - Discontinued Products (Contd..2), H2 2016 714 Asthma - Discontinued Products (Contd..3), H2 2016 715 Asthma - Discontinued Products (Contd..4), H2 2016 716 Asthma - Discontinued Products (Contd..5), H2 2016 717 Asthma - Discontinued Products (Contd..6), H2 2016 718 Asthma - Discontinued Products (Contd..7), H2 2016 719 Asthma - Discontinued Products (Contd..8), H2 2016 720
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
